Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN
NCT03131076 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2017-04-27
Summary
Over 500 patients were participating in the IPMN follow up between september 2014 and august 2016 at the Helsinki University Hospital. In this study we are going to determine the effects of the IPMN surveillance on the quality of life and anxiety levels of the patients.
Conditions
- IPMN
- Quality of Life
Interventions
- DIAGNOSTIC_TEST
-
IPMN follow up
Follow up with MRI and laboratory blood tests
Sponsors & Collaborators
-
Helsinki University Central Hospital
lead OTHER
Principal Investigators
-
Heini Nieminen · Helsinki Universtity Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-01
- Primary Completion
- 2018-08-31
- Completion
- 2019-12-31
More Related Trials
-
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute
NCT02655744 ·Status: RECRUITING
-
Predictors of Mortality and Morbidity in the Surgical Management of Primary Tumors of the Spine
NCT01643174 ·Status: COMPLETED
-
Protoporphyrin Imaging in Multispectral Evaluation of Resections
NCT07021573 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neurococognitive and Functioal Assessment of Patients With Brain Metastases
NCT01861405 ·Status: UNKNOWN
-
A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline
NCT02504788 ·Status: RECRUITING ·Phase: NA
-
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
NCT05259605 ·Status: RECRUITING
-
68Ga-P16-093 PET/CT Imaging in Glioma Patients
NCT05569434 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL)
NCT02397733 ·Status: COMPLETED ·Phase: NA
-
Establishing Radiolabelled PSMA as a Target for Glioma Treatment
NCT05263466 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Proton Radiation For Meningiomas and Hemangiopericytomas
NCT01117844 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors
NCT00278239 ·Status: UNKNOWN
-
Hippocampus Avoidance PCI vs PCI
NCT01780675 ·Status: COMPLETED ·Phase: PHASE3
-
Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors
NCT00710151 ·Status: TERMINATED
-
11C-Methionine PET as Prognostic Marker of Gliomas
NCT02518061 ·Status: COMPLETED
-
The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)
NCT06962215 ·Status: RECRUITING ·Phase: NA
-
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
NCT06381726 ·Status: RECRUITING ·Phase: NA
-
Multimodal Imaging of Hypoxia in Gliomas
NCT03716986 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Study on Leptomeningeal Metastasis of Solid Tumors
NCT06705049 ·Status: ENROLLING_BY_INVITATION
-
Brain Metastases in Norway - A Prospective Cohort Study
NCT03346655 ·Status: ACTIVE_NOT_RECRUITING
-
Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
NCT00911729 ·Status: TERMINATED
-
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors
NCT06209567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway
NCT02851355 ·Status: COMPLETED
-
Quality of Life and Patient Needs in Advanced High Grade Gliomas
NCT05039346 ·Status: COMPLETED
-
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
NCT05576103 ·Status: RECRUITING
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
NCT02544022 ·Status: RECRUITING